0001209191-23-041805.txt : 20230707
0001209191-23-041805.hdr.sgml : 20230707
20230707163517
ACCESSION NUMBER: 0001209191-23-041805
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230705
FILED AS OF DATE: 20230707
DATE AS OF CHANGE: 20230707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chacko Jacob
CENTRAL INDEX KEY: 0001608936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 231077189
MAIL ADDRESS:
STREET 1: C/O IGNYTA, INC.
STREET 2: 11095 FLINTKOTE AVE., SUITE D
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001796280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471787157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 388-5600
MAIL ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-05
0
0001796280
Oric Pharmaceuticals, Inc.
ORIC
0001608936
Chacko Jacob
C/O ORIC PHARMACEUTICALS, INC.
240 E. GRAND AVE., 2ND FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
0
Common Stock
2023-07-05
4
S
0
4336
8.0052
D
796316
D
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022.
Represents the weighted average share price of an aggregate total of 4,336 shares sold in the price range of $8.00 to $8.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Christian Kuhlen, attorney-in-fact
2023-07-07